CGP identifies TP53 and SMAD4 mutations as negative prognostic markers, while PTEN mutations correlate with improved survival in CRC patients. Despite no significant survival advantage, CGP-guided ...

Such genomic technologies not only help to identify cancers, but also offer opportunities for assessing the potential efficacy of different treatment options. By analyzing the genomic profile of a ...

Precision medicines and personalized treatments are revolutionizing cancer therapy. Small molecules, biological agents, antibody-drug conjugates and cell-based therapies directed against specific ...

Comprehensive Genomic Profiling for Resectable Pancreatic Cancer: The Earlier the Better? The following represents disclosure information provided by authors of this manuscript. All relationships are ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted therapies for patients diagnosed with cancer. Rather than analyzing one gene at a ...

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train artificial ...

Led by a team from Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center, researchers have created the largest and most detailed profile of genetic mutations found in African American women ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

New QIAseq panels launched for use on next-generation sequencers to boost analysis of over 700 genes for comprehensive genomic profiling in research and clinical applications Advancing key ...

We performed a single-institution, retrospective analysis of CGP utilization and treatment patterns in patients with localized PDAC who underwent curative-intent resection in the contemporary period ...

Study published in ‘Cell Reports Methods’ demonstrates the strength of Tagomics’ platform for epigenomic biomarker discovery and applications in liquid biopsy Activace platform enables targeted, ...